Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
0 investors
Curelab Oncology develops anti-cancer drugs with a focus on gene therapy and immuno-oncology, taking programs from early discovery through clinical development. It is a biotech company operating in the oncology drug development space.
0 investors
CureLab Veterinary develops ElenaVet, a plasmid DNA gene therapy encoding the p62/SQSTM1 protein to reduce chronic inflammation and enhance anticancer immune response in pets, targeting conditions such as breast cancer, melanoma, osteoarthritis and inflammatory bowel disease in dogs, cats and horses. The company works with academic and private veterinary clinics through comparative medicine studies and is a sister company of CureLab Oncology, which focuses on human immuno-oncology.
0 investors
Curemark is a clinical-stage biopharmaceutical company developing therapies for neuro-developmental and neurodegenerative disorders. Its lead candidate, CM-AT, is a disorder-modifying therapy for Autism.
0 investors
Curza develops new classes of broad-spectrum antibiotics targeting drug-resistant ESKAPE pathogens, including Gram-negative bacteria and biofilm-related infections. Its lead program, CZ-02, targets an unexploited binding site of the bacterial ribosome.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
CYduct Diagnostics (CYductDX) develops and markets medical devices for breast cancer risk assessment, early detection, and diagnosis through an intraductal approach within the mammary ducts. It serves women and their clinicians, applying genetic and proteomic testing to breast health in the medical device and diagnostics industry.
0 investors
0 investors
0 investors
0 investors
Cypris Medical develops minimally-invasive medical devices and treatments designed specifically for plastic surgeons to deliver results comparable to traditional surgery with shorter recovery times. The company combines medical device expertise with input from practicing surgeons to address unmet needs in the plastic surgery market.
0 investors
Cyprium Therapeutics develops therapies for rare genetic diseases, with a focus on treatments for Menkes disease. The company's pipeline includes ZYCUBO (copper histidinate) and AAV-ATP7A gene therapy candidates.
0 investors
Cyrcadia Health develops technology based on circadian rhythm science to detect tissue disruption and cancer risk. The company's core innovation relates circadian clock dysregulation to cancer development and prognosis.
0 investors
0 investors
0 investors
0 investors
0 investors
CytoDyn is a biopharmaceutical company conducting clinical trials, including a Phase 2 colorectal cancer trial.
0 investors
0 investors